Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue 4, 1997, Pages 206-212

  Zumbach, M ^a   Hofmann, M ^a   Borcea, V ^a   Luther, Th ^b   Kotzsch, M ^b   Muller M ^b   Hergesell, O ^a   Andrassy, K ^a   Ritz, E ^a   Ziegler, R ^a   Wahl, P ^a   Nawroth, P P ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Diabetes mellitus; Tissue factor

Indexed keywords

ALBUMIN; CREATININE; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEINURIA;

EID: 8544228322     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211753     Document Type: Article

References (56)

1. Abel M, Ritthaler U, Zhang Y, Deng Y, Schmidt AM, Greten J, Sernau T, Wahl P, Andrassy K, Ritz E, Waldherr R, Stern DM, Nawroth PP: Expression of receptors for advanced glycosylated end-products in renal disease. Nephrol Dial Transplant 10: 1662-1667, 1995
2. Albrecht S, Luther T, Großmann H, Flössel C, Kotzsch M, Müller M: An ELISA for tissue factor using monoclonal antibodies. Blood Coagul Fibrinolysis 3: 263-270, 1992
3. Albrecht S, Müller S, Siegert G, Luther T, Müller M: Plasma concentration of tissue factor and factor VII in patients after abdominal surgery. Thromb Res 77: 557-562, 1995
4. Andree H, Nemerson Y: Tissue factor: regulation of activity by flow and phosholipid surfaces. Blood Coagul Fibrinolysis 6: 189-197, 1995
5. Bach RR: Initiation of coagulation by tissue factor. Crit Rev Biochem Mol Biol 23: 339-348, 1988
6. Bayness JW: Role of oxidative stress in development of complications of diabetes. Diabetes 40: 405-412, 1991
7. Bierhaus A, Hemmer C, Mackman N, Kutob R, Ziegler R, Dietrich M, Nawroth PP: Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NFkB activation. Thromb Haemost 73: 39-48, 1995a
8. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Müller M, Böhrer H, Greten J, Martin E, Baeuerle PA, Waldherr R, Kisiel W, Ziegler R, Stern DM, Nawroth PP: Mechanism of the Tumor Necrosis Factor α-mediated Induction of Endothelial Tissue Factor. J Biol Chem 270: 26419-26432, 1995b
9. Bloem LJ, Chen L, Konigsberg WH, Bach R: Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearence of tissue factor antigen and procoagulant activity. J Cell Physiol 139: 418-423, 1989
10. Boeri D, Almus FE, Maiello M, Cagliero E, Rao LVM, Lorenzi M: Modification of tissue -factor mRNA and protein response to thrombin and interleukin 1 by high glucose in cultured human endothelial cells. Diabetes 38: 212-218, 1989
11. Boyd-White J, Williams JC, Jr: Effect of cross-linking on matrix permeability. Diabetes 45: 348-353, 1996
12. Carson SD, Brozna JP: The role of tissue factor in the production of thrombin. Blood Coagul Fibrinolysis 4: 281-292, 1993
13. Ceriello A: Coagulation activation in diabetes mellitus: the role of hyperglycemia and therapeutic prospects. Diabetologia 36: 1119-1125, 1993
14. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, Pirisi M, Falleti E, Bartoli E: Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 44: 924-928, 1995
15. Clauss M, Murray JC, Vianna V, DeWaal R, Thurston G, Nawroth PP, Gerlach H, Bach R, Familletti PC, Stern DM: A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/ chachectin. J Biol Chem 265: 7078-7083, 1990
16. Davis MD, Hubbard LD, Tarutmann J: Studies of retinopathy; methodology assessment and classification with fundus photographs. Diabetes 35 (Suppl 3): 42-49, 1985
17. Drake DA, Morrissey JH, Edgington TS: Selective cellular expression of tissue factor in human tissues. Am J Pathol 134: 1087-1097, 1989
18. Edington TS, Mackman N, Brand K, Ruf W: The structural biology of expression and function of tissue factor. Thromb Haemost 66: 67-79, 1991
19. Esposito C, Gerlach H, Brett J, Stern DM, Vlassara H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170: 1387-1407, 1989
20. Fleck RA, Rao LVM, Rapaport SI, Varki N: Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal antihuman tissue factor antibody. Thromb Res 59: 421-437, 1990
21. Flössel C, Luther T, Müller M, Albrecht S, Kasper M: Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochemistry 101: 449-453, 1994
22. Fuller JH, Keen H, Jarret RJ, Omer T, Meade TW, Chakrabarti R, North WRS, Stirling Y: Haemostatic variables associated with diabetes mellitus and its complications. B M J 2: 964-966, 1979
23. Gabath S, Keller C, Kempe HP, Amiral J, Ziegler R, Ritz E, Bergis KH, Wahl P, Nawroth PP: Plasma thrombomodulin: A marker of vascular complications in diabetes. VASA, 1996 25: 233-241
24. Giercksky KE, Bjorklid E, Prydz H, Renck H: Circulating tissue thromboplastin during hip surgery. Eur Surg Res 11: 296-300, 1979
25. Greten J, Kreis I, Wiesel K, Stier E, Schmidt AM, Stern DM, Ritz E, Waldherr R, Nawroth PP: Receptors for advance glycation end-products (AGE) expression by endothelial cells in non-diabetic uraemic patients. Nephrol Dial Transplant 11: 786-790, 1996
26. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G: PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 43: 426-429, 1994
27. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88: 11555-11558, 1991
28. Hergesell O, Andrassy K, Geberth S, Nawroth P, Gabath S: Plasma thrombomodulin levels are dependent on renal function. Thromb Res 72: 455-458, 1993
29. Iwashima Y, Sato T, Watanabe K, Ooshima E, Hiraishi S, Ishii H, Kazama M, Makino I: Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes 39: 983-988, 199
30. Jensen T: Increased plasma concentration of von Willebrand factor in insulin-dependent diabetics with incipient nephropathy. B M J 298: 27-28, 1989
31. Jensen T, Stender S, Deckert T: Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type I (insulin-dependent) diabetic patients with increased albumin excretion. Diabetologia 31: 142-145, 1988
32. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC: Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. B M J 298: 487-490, 1989
33. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T: Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol 15: 1114-1120, 1995
34. Kario K, Sakata T, Matsuo T, Miyata T: Factor VII in non-insulin-dependent diabetic patients with microalbuminuria. Lancet 342: 1552, 1993. Letter.
35. Kirstein M, Brett J, Radoff S, Ogawa S, Stern DM, Vlassara H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87: 9010-9014, 1990
36. Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, Kuriyama R, Matsuzawa K, Hasegawa R, Aoki N: Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 87: 343-347, 1994
37. Kubota T, Andoh K, Sadakata H, Tanaka H, Kobayashi N: Tissue factor releasead from leukemic cells. Thromb Haemost 65: 59-63, 1991
38. Lee P, Jenkins A, Bourke C, Santamaria J, Paton C, Janus E, Best J: Prothrombotic and antithrombotic factors are elevated in patients with type 1 diabetes complicated by microalbuminuria. Diabet Med 10: 122-128, 1993
39. 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. Diabetes 42: 233-238, 1993
40. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern DM: Tumor necrosis factor/ cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 163: 1363-1375, 1986c
41. Nawroth PP, Handley D, Esmon CT, Stern DM: Interleukin 1 induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 83: 3460-3464, 1986a
42. Nawroth PP, Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740-745, 1986b
43. Nawroth PP, Stern DM, Kisiel W, Bach R: Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Thromb Res 40: 677-691, 1985
44. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP: Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44: 1054-1058, 1995
45. Rapaport SI, Rao LVM: Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb. 12: 1111-1121, 1992
46. Ritthaler U, Deng Y, Zhang Y, Greten J, Abel M, Sido B, Allenberg J, Otto G, Roth H, Bierhaus A, Ziegler R, Schmidt AM, Waldherr R, Wahl P, Stern DM, Nawroth PP: Expression of receptors for advanced glycation end-products in peripheral occlusive vascular disease. Am J Pathol 146: 688-694, 1995
47. Schmidt AM, Hasu M, Popov D, Zhang JH, Chen J, Yan SD, Brett J, Cao R, Kuwabara K, Costache G, Simionescu N, Simionescu M, Stern DM: Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci USA 912: 8807-8811, 1994
48. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern DM: Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 92: 2155-2168, 1993
49. Sernau T, Wilhelm C, Seyfert U, Gabath S, Henkels M, Amiral J, Bergis KH, Ziegler R, Wahl P, Nawroth PP: Thrombomodulin ist ein Marker für mikrovaskuläre, aber nicht für makrovaskuläre Endothelschädigung. VASA 24: 347-353, 1995
50. Stern DM, Esposito C, Gerlach H, Gerlach M, Ryan J, Handley D, Nawroth PP: Endothelium and the regulation of coagulation. Diabetes Care 14:160-166, 1991
51. Takahashi T, Satoh N, Wada K, Takakuwa E, Seki Y, Shibata A: Tissue factor in plasma of patients with disseminated intravascular coagulation. Am J Hematol 46: 333-337, 1994
52. 2-plasmin inhibitor complex. Thromb Res 55: 727-735, 1989
53. Wada H, Nakase T, Nakaya R, Minamikawa K, Wakita Y, Kaneko T, Ohiwa M, Deguchi K, Shirakawa S: Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol 45: 232-236, 1994
54. Weiss HJ, Lages B: Evidence for tissue factor dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood 71: 629-635, 1988
55. Yokoyama H, Myrup B, Rossing P, Ostergaard PB: Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy. Diabetes Care 19: 441-445, 1996
56. Zhang Y, Deng Y, Wendt T, Liliensiek B, Bierhaus A, Greten J, He W, Chen B, Hach-Wunderle V, Waldherr R, Ziegler R, Männel D, Stern DM, Nawroth PP: Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-a sarcomas. J Clin Invest 97: 2213-2224, 1996